4.7 Article

Amino acid transport system L activity in developing mouse ovarian follicles

期刊

HUMAN REPRODUCTION
卷 26, 期 11, 页码 3102-3108

出版社

OXFORD UNIV PRESS
DOI: 10.1093/humrep/der298

关键词

ovary; follicles; insulin-like growth factor 1; amino acid transport; metabolism

资金

  1. University of Otago
  2. New Zealand Vice-Chancellors Committee award

向作者/读者索取更多资源

BACKGROUND: Little is known about metabolic processes in the developing ovarian follicle. Using mouse ovarian follicles, we investigated uptake of L-leucine by follicles at varying stages of maturity in the presence of insulin-like growth factor (IGF)-1. METHODS: Mouse ovarian follicles were cultured in vitro for 5 days in increasing concentrations of IGF-1, and follicle diameter and atresia measured as endpoints for growth. Uptake of H-3-leucine was measured in follicles at different stages of development. In optimal IGF-1-mediated growth conditions, competitive inhibition of H-3-leucine uptake by 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), a non-metabolizable substrate analogue of L-leucine, was performed to demonstrate specificity of influx, via system L transporters. To test whether uptake rates were dependent on intracellular amino acid availability, follicles from in vitro cultures were pre-treated with L-phenylalanine prior to H-3-leucine uptake. RESULTS: Follicle development (P < 0.001) and survival (P < 0.001) increased with IGF-1 treatment. As pre-antral follicles progressed to late antral stage, we observed an increase in L-leucine uptake, which was reduced in pre-ovulatory follicles. BCH decreased L-leucine uptake rates in early antral (P < 0.05), antral (P < 0.001) and pre-ovulatory follicles (P < 0.01). L-leucine influx increased in follicles preloaded with phenylalanine (trans-stimulation). In follicles lacking free intracellular amino acids (zero-trans suppression), uptake rate was reduced (P < 0.05). CONCLUSIONS: These results demonstrate, for the first time, evidence of specific system L amino acid transport in intact, mouse ovarian follicles and profile L-leucine uptake during folliculogenesis. A better understanding of ovarian follicle metabolic pathways is necessary for improved in vitro maturation as well as determining the impact of altered metabolism on fertility.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Peripheral Vascular Disease

Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta

Tu'uhevaha J. Kaitu'u-Lino, Fiona C. Brownfoot, Roxanne Hastie, Ashwini Chand, Ping Cannon, Minh Deo, Laura Tuohey, Clare Whitehead, Natalie J. Hannan, Stephen Tong

HYPERTENSION (2017)

Article Immunology

ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling

Stefanie Schmidt, Neele Schumacher, Jeanette Schwarz, Simone Tangermann, Lukas Kenner, Michaela Schlederer, Maria Sibilia, Markus Linder, Annelore Altendorf-Hofmann, Thomas Knoesel, Elisabeth S. Gruber, Georg Oberhuber, Julia Bolik, Ateequr Rehman, Anupam Sinha, Juliane Lokau, Philipp Arnold, Anne-Sophie Cabron, Friederike Zunke, Christoph Becker-Pauly, Adele Preaudet, Paul Nguyen, Jennifer Huynh, Shoukat Afshar-Sterle, Ashwini L. Chand, Juergen Westermann, Peter J. Dempsey, Christoph Garbers, Dirk Schmidt-Arras, Philip Rosenstiel, Tracy Putoczki, Matthias Ernst, Stefan Rose-John

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Meeting Abstract Oncology

IL-11 as a therapeutic target to treat colorectal cancer

Jennifer Huynh, Ashwini Chand, Matthias Ernst

CANCER RESEARCH (2018)

Article Medicine, Research & Experimental

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth

Pathum Thilakasiri, Jennifer Huynh, Ashleigh R. Poh, Chin Wee Tan, Tracy L. Nero, Kelly Tran, Adam C. Parslow, Shoukat Afshar-Sterle, David Baloyan, Natalie J. Hannan, Michael Buchert, Andrew Mark Scott, Michael D. W. Griffin, Frederic Hollande, Michael W. Parker, Tracy L. Putoczki, Matthias Ernst, Ashwini L. Chand

EMBO MOLECULAR MEDICINE (2019)

Review Oncology

Repurposing of drugs as STAT3 inhibitors for cancer therapy

Pathum S. Thilakasiri, Rhynelle S. Dmello, Tracy L. Nero, Michael W. Parker, Matthias Ernst, Ashwini L. Chand

Summary: Drug repurposing is a valuable approach for rapidly introducing new cancer therapies into clinical practice. STAT3 inhibitors play a significant role in cancer treatment, but challenges remain in understanding the mechanisms of STAT3 activation and developing strategies to suppress its activity with various pharmaceutical agents.

SEMINARS IN CANCER BIOLOGY (2021)

Article Oncology

Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice

Ashleigh R. Poh, Amy R. Dwyer, Moritz F. Eissmann, Ashwini L. Chand, David Baloyan, Louis Boon, Michael W. Murrey, Lachlan Whitehead, Megan O'Brien, Clifford A. Lowell, Tracy L. Putoczki, Fiona J. Pixley, Robert J. J. O'Donoghue, Matthias Ernst

CANCER IMMUNOLOGY RESEARCH (2020)

Review Pharmacology & Pharmacy

Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments

Marcos Perini, Rhynelle S. Dmello, Tracy L. Nero, Ashwini L. Chand

PHARMACOLOGY & THERAPEUTICS (2020)

Review Biochemistry & Molecular Biology

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer

Rhynelle S. Dmello, Sarah Q. To, Ashwini L. Chand

Summary: Liver metastasis is a significant factor in the mortality of colorectal cancer patients. Understanding the cellular interactions in the tumor microenvironment can lead to the development of new therapeutic targets for metastatic colorectal cancer, despite current treatment challenges.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

STAT3 Signalling via the IL-6ST/gp130 Cytokine Receptor Promotes Epithelial Integrity and Intestinal Barrier Function during DSS-Induced Colitis

Lokman Pang, Jennifer Huynh, Mariah G. Alorro, Xia Li, Matthias Ernst, Ashwini L. Chand

Summary: Reduced STAT3 activity in mice leads to increased susceptibility to DSS-induced colitis, indicating that the IL-6/gp130/STAT3 signaling pathway orchestrates intestinal barrier function by modulating cytokine secretion and promoting epithelial integrity to maintain defense against bacteria. Therapeutically targeting this signaling axis may serve as a treatment strategy for IBD patients.

BIOMEDICINES (2021)

Article Oncology

Host IL11 Signaling Suppresses CD4+ T cell-Mediated Antitumor Responses to Colon Cancer in Mice

Jennifer Huynh, David Baloyan, David Chisanga, Wei Shi, Megan O'Brien, Shoukat Afshar-Sterle, Mariah Alorro, Lokman Pang, David S. Williams, Adam C. Parslow, Pathum Thilakasiri, Moritz F. Eissmann, Louis Boon, Frederick Masson, Ashwini L. Chand, Matthias Ernst

Summary: IL11 is a member of the IL6 family of cytokines, and plays a role in regulating CD4+ T cell-mediated antitumor responses by suppressing the activity of host CD4(+) T cells in the tumor microenvironment. This suggests a potential immunomodulatory role for IL11 in colon cancer development that could be targeted for anticytokine-based therapy.

CANCER IMMUNOLOGY RESEARCH (2021)

Review Oncology

STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential

Sarah Q. To, Rhynelle S. Dmello, Anna K. Richards, Matthias Ernst, Ashwini L. Chand

Summary: This review explores the role of the STAT3 signaling pathway in breast cancer and its correlation with disease progression and metastasis. The study discusses the function of this signaling cascade in the tumor microenvironment, as well as the contribution of IL-6 family cytokines to cancer and potential therapeutic targets.

CANCERS (2022)

Meeting Abstract Oncology

Repurposing bazedoxifene to suppress gastrointestinal cancer growth

Pathum Thilakasiri, Tracy Nero, Michael W. Parker, Matthias Ernst, Ashwini L. Chand

CANCER RESEARCH (2019)

Meeting Abstract Oncology

Targeting the myeloid-cell specific SRC-kinase HCK improves anti-tumor immunity

Matthias R. Ernst, Ashwini Chand, Nicholas Huntington, Robert O'Donoghue, Ashleigh Poh

CANCER RESEARCH (2019)

Review Oncology

Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map

Jennifer Huynh, Ashwini Chand, Daniel Gough, Matthias Ernst

NATURE REVIEWS CANCER (2019)

Article Oncology

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma

Rhiannon Coulson, Seng H. Liew, Angela A. Connelly, Nicholas S. Yee, Siddhartha Deb, Beena Kumar, Ana C. Vargas, Sandra A. O'Toole, Adam C. Parslow, Ashleigh Poh, Tracy Putoczki, Riley J. Morrow, Mariah Alorro, Kyren A. Lazarus, Evie F. W. Yeap, Kelly L. Walton, Craig A. Harrison, Natalie J. Hannan, Amee J. George, Colin D. Clyne, Matthias Ernst, Andrew M. Allen, Ashwini L. Chand

ONCOTARGET (2017)

暂无数据